Ann: Appendix 4C Quarterly Cashflow and commentary, page-84

@flesko37

v kind. i actually planned to do an investing blog when i left my last role and HC was a trial run. But I found 95% of people arent after knowledge or balanced discussion - just confirmation of their own bias - so canned the idea

hence why fox News and ZeroHedge are so successful and why I'd be a v poor publisher

will take a look at PNV but with caveat I dont have much biotech specific knowledge and i loathe the sector as an investment propostion until v late stage in approval process. endless capital raisings mean even great science frequently doesnt translate to even OK investment returns. its worse than junior miners.

OSL is one biotech i think is close to getting interesting. SRX-style upside and in final cooee of approval as i understand it. But I havent done enough work on it.

but ill take a look at PNV when I can and let you know on that forum if I see anything worth saying